fda glp-1 enforcement news is moving to restrict mass-marketed compounded products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger to protect patients from unverified Fifth Circuit probes FDA ban

& Ghosh, J

First, the current body of evidence lacks large-scale, long-term randomized controlled trials (RCTs) evaluating the sustained effects of specific diets and herbal supplements in diverse populations

These studies do not establish that adding 5-Amino-1MQ to a human calorie-reduction plan produces additional weight loss

Characterizing body composition modifying effects of a glucagon-like peptide 1 receptor-based agonist: A meta-analysis

Endoscopic carpal tunnel release through one or two very small (less than 1 cm) incisions, a tiny camera and specialized cutting instrument are used to divide the ligament from inside the tunnel

However, data is extremely limited